Company research / HQY

Healthequity, Inc. (HQY)

SEC name HEALTHEQUITY, INC. · CIK 0001428336 · Nasdaq · Services-Business Services, NEC

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Jan 31

For the year ended 2026-01-31, Healthequity, Inc. reported revenue of $1.31B. Revenue grew 9.5% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $1.36B.

Key ratios (year ended 2026-01-31)

69.5%
Gross margin
24.6%
Operating margin
16.4%
Net margin
10.2%
Return on year-end equity
9.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31
2026-01-312025-01-312024-01-312023-01-312022-01-312021-01-312020-01-312019-01-312018-01-312017-01-31
Revenue$1.36B$1.31B$1.20B$999.59M$861.75M$756.56M$733.57M$531.99M$287.24M$229.53M$178.37M
Cost of Revenue$391.65M$400.31M$422.51M$376.95M$369.81M$331.79M$318.24M$206.08M$106.05M$94.61M$72.02M
Gross Profit$970.48M$913.12M$777.26M$622.64M$491.94M$424.76M$415.33M$325.91M$181.19M$134.92M$106.36M
R&D Expense$277.96M$262.51M$239.51M$218.81M$193.38M$157.36M$124.81M$77.58M$35.06M$27.39M$22.38M
Operating Income$351.41M$322.46M$162.33M$117.70M$9.06M-$24.24M$34.01M$77.01M$77.67M$54.42M$41.21M
Depreciation & Amortization$157.63M$154.66M$162.45M$153.08M$161.20M$137.19M$115.90M$55.35M$18.18M$15.95M$13.19M
EBITDA$509.04M$477.11M$324.79M$270.78M$170.26M$112.95M$149.92M$132.36M$95.86M$70.37M$54.40M
Net Income$236.49M$215.20M$96.70M$55.71M-$26.14M-$44.29M$8.83M$39.66M$73.90M$47.36M$26.38M
EPS (Diluted)n/a$2.46$1.09$0.64-$0.31-$0.53$0.12$0.58$1.17$0.77$0.44
Total Assets$3.27B$3.38B$3.45B$3.16B$3.09B$3.11B$2.71B$2.56B$510.02M$369.16M$279.14M
Total Liabilities$1.28B$1.27B$1.33B$1.13B$1.19B$1.25B$1.33B$1.53B$32.94M$22.89M$17.20M
Long-Term Debt$931.06M$957.38M$1.06B$874.97M$925.34M$930.83M$986.72M$1.22Bn/an/an/a
Shareholders' Equity$1.99B$2.11B$2.11B$2.04B$1.90B$1.85B$1.38B$1.03B$477.08M$346.27M$261.94M
Cash & Equivalents$256.00M$318.93M$295.95M$403.98M$254.27M$225.41M$328.80M$191.73M$361.48M$199.47M$139.95M
Operating Cash Flow$490.18M$457.09M$339.86M$242.83M$150.65M$141.00M$181.62M$105.01M$113.42M$81.70M$45.59M
Capital Expenditures$2.45M$1.97M$2.08M$1.69M$3.37M$8.91M$13.09M$7.29M$3.87M$5.46M$3.65M
Free Cash Flow$487.73M$455.12M$337.77M$241.13M$147.28M$132.09M$168.53M$97.72M$109.55M$76.24M$41.95M
Share Repurchases$404.50M$299.25M$121.49M$0$0n/an/an/an/an/an/a
Dividends Paidn/an/an/an/an/an/an/an/an/an/a$0
Shares Outstanding82.91M85.01M86.54M86.13M84.76M83.78M77.17M71.05M62.45M60.83M59.54M
Weighted Average Diluted Sharesn/a87.47M88.83M86.96M84.44M83.13M75.68M68.45M63.37M61.85M59.89M
EPS (Basic)n/a$2.50$1.11$0.65-$0.31-$0.53$0.12$0.59$1.20$0.79$0.45

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView